Kevin Weber
Neurology · Gahanna, OHNPI 1770875759
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,825 of the $6,825 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Avid Radiopharmaceuticals, Inc..
Across 5 payments — averaging $1365.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avid Radiopharmaceuticals, Inc.$7K
Across 22 payments — averaging $7307.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$94K
- Eli Lilly$67K
What the payments were for
- Consulting fees$6,825100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avid Radiopharmaceuticals, Inc. | 5 | $6,825 |
How this compares
$6,825 in reported general payments places this provider in the 70th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 62 | $96,280 |
| Nurtec OdtRimegepant Sulfate | 35 | $58,442 |
| QuliptaAtogepant | 35 | $43,154 |
| Emgality PenGalcanezumab-Gnlm | 46 | $29,053 |
| Aimovig AutoinjectorErenumab-Aooe | 33 | $25,551 |
| Dihydroergotamine Mesylate | 13 | $24,745 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 25 | $21,519 |
| Sumatriptan Succinate | 81 | $8,593 |
| Topiramate ErTopiramate | 11 | $7,590 |
| Naratriptan Hcl | 95 | $3,932 |
| Methocarbamol | 58 | $3,594 |
| Gabapentin | 134 | $2,951 |
| Candesartan Cilexetil | 25 | $2,392 |
| RizatriptanRizatriptan Benzoate | 160 | $1,781 |
| Memantine Hcl | 39 | $1,434 |
Paid to pharmacies, not to this prescriber.
Other neurology in Gahanna
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Lawrence ElmerToledo$687K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
- Geoffrey EubankColumbus$508K
- Lawrence GoldstickDayton$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.